We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Celgene Corporation | NASDAQ:CELGZ | NASDAQ | Right |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.469899 | 0.41 | 0.48 | 0 | 01:00:00 |
Delaware
|
001-34912
|
22-2711928
|
(State or other Jurisdiction of Incorporation or Organization)
|
(Commission File Number) | (I.R.S. Employer Identification No.) |
Large accelerated filer
|
☒
|
Accelerated filer
|
☐
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
☐
|
|
|
Emerging growth company
|
☐
|
• |
Registration Statement No. 333-42302, registering 4,144,255 common shares, par value $0.01 per share (the “Common Stock”), of Celgene Corporation (“Celgene”) in connection with the acquisition of Signal Pharmaceuticals, Inc.
|
• |
Registration Statement No. 333-101196, registering 2,986,723 shares of Common Stock in connection with the acquisition of Anthrogenesis Corp.
|
• |
Registration Statement No. 333-148777, registering 31,586,420 shares of Common Stock in connection with the acquisition of Pharmion Corporation.
|
• |
Registration Statement No. 333-168369, registering 11,300,440 shares of Common Stock and 43,430,895 contingent value rights in connection with the acquisition of Abraxis BioScience, Inc.
|
|
Celgene Corporation
|
|
/s/ Katherine R. Kelly
|
|
By: Katherine R. Kelly
|
|
Title: Secretary
|
1 Year Celgene Chart |
1 Month Celgene Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions